 |
|
Clinical Features of Staphylococcus aureus Endocarditis
A 10-Year Experience in Denmark
Bent L. Røder, MD;
Dorte A. Wandall, MD;
Niels Frimodt-Møller, MD, DMSc;
Frank Espersen, MD, DMSc;
Peter Skinhøj, MD, DMSc;
Vibeke T. Rosdahl, DMSc
Arch Intern Med. 1999;159:462-469.
Background Both morbidity and mortality resulting from Staphylococcus aureus endocarditis are known to be high, and the incidence of this disease seems to increase. The Statens Serum Institut, Copenhagen, Denmark, made it possible for us to analyze the clinical features of S aureus endocarditis in a nation-wide population of non–drug addicts.
Methods Almost all Danish cases of bacteremia due to S aureus are reported to the Staphylococcus laboratory, Statens Serum Institut. The medical records were reviewed in cases reported from 1982 to 1991 in which the diagnosis of endocarditis was reported or suspected.
Results A total of 260 patients, 145 males and 115 females, fulfilled the diagnostic criteria. The median age was 67.5 years. In 83 patients, the diagnosis of endocarditis was not suspected clinically. The overall mortality rate among those patients whose disease was diagnosed clinically was 46%. Among the subset of patients who received medical therapy only and appropiate antistaphylococcal treatment, mortality was significantly associated with late congestive heart failure, age, and involvement of the central nervous system.
Conclusions A raised awareness of the paucity of clinical findings and a more frequent use of echocardiography as a screening method seem essential to improve the prognosis of patients with S aureus endocarditis. Involvement of the central nervous system constitutes a relative indication of early valve replacement.
From the Division of Microbiology, Statens Serum Institut (Drs Røder, Wandall, Frimodt-Møller, Espersen, and Rosdahl), and the Department of Infectious Diseases, Rigshospitalet (Dr Skinhøj), Copenhagen, Denmark. Dr Røder is now with the Department of Clinical Microbiology, Hillerød Sygehus, Hillerød, Denmark.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Remadi et al.
Ann. Thorac. Surg. 2007;83:1295-1302.
ABSTRACT
| FULL TEXT
Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens
Nadji et al.
Heart 2005;91:932-937.
ABSTRACT
| FULL TEXT
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler et al.
JAMA 2005;293:3012-3021.
ABSTRACT
| FULL TEXT
Temporal Trends in Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota
Tleyjeh et al.
JAMA 2005;293:3022-3028.
ABSTRACT
| FULL TEXT
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT
| FULL TEXT
Infective endocarditis in Europe: lessons from the Euro heart survey
Tornos et al.
Heart 2005;91:571-575.
ABSTRACT
| FULL TEXT
Early Predictors of In-Hospital Death in Infective Endocarditis
Chu et al.
Circulation 2004;109:1745-1749.
ABSTRACT
| FULL TEXT
Endocarditis diagnosed as multilobar, community acquired pneumonia
Muntan and Haydel
Emerg. Med. J. 2004;21:244-245.
FULL TEXT
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary: The Task Force on Infective Endocarditis of the European Society of Cardiology
Task Force Members et al.
Eur Heart J 2004;25:267-276.
FULL TEXT
Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler et al.
Arch Intern Med 2003;163:2066-2072.
ABSTRACT
| FULL TEXT
Role of staphylococcal enterotoxin A in a fatal case of endocarditis
Ellis et al.
J Med Microbiol 2003;52:109-112.
ABSTRACT
| FULL TEXT
In Vitro Antibacterial Activities of Phloxine B and Other Halogenated Fluoresceins against Methicillin-Resistant Staphylococcus aureus
Rasooly and Weisz
Antimicrob. Agents Chemother. 2002;46:3650-3653.
ABSTRACT
| FULL TEXT
Changing Profile of Infective Endocarditis: Results of a 1-Year Survey in France
Hoen et al.
JAMA 2002;288:75-81.
ABSTRACT
| FULL TEXT
Unique Features of Infective Endocarditis in Childhood
Ferrieri et al.
Pediatrics 2002;109:931-943.
FULL TEXT
Unique Features of Infective Endocarditis in Childhood
Ferrieri et al.
Circulation 2002;105:2115-2126.
FULL TEXT
Treatment and Outcome of Staphylococcus aureus Bacteremia: A Prospective Study of 278 Cases
Jensen et al.
Arch Intern Med 2002;162:25-32.
ABSTRACT
| FULL TEXT
Changing Patient Characteristics and the Effect on Mortality in Endocarditis
Cabell et al.
Arch Intern Med 2002;162:90-94.
ABSTRACT
| FULL TEXT
Infective Endocarditis in Adults
Mylonakis and Calderwood
NEJM 2001;345:1318-1330.
FULL TEXT
Neurologic Manifestations of Infective Endocarditis: A 17-Year Experience in a Teaching Hospital in Finland
Heiro et al.
Arch Intern Med 2000;160:2781-2787.
ABSTRACT
| FULL TEXT
|
